A Photoaffinity Probe Covalently Modifies the Catalytic Site of the cGMP-Binding cGMP-Specific Phosphodiesterase (PDE-5)

Cell Biochemistry and Biophysics

Volumn 29, Issue 1-2, 1998, Pages 145-157

  Corbin, Jackie D ^a   Beasley, Alfreda ^a   Turko, Illarion V ^a   Haik, Tamara L ^a   Mangum, Kimberly A ^a   Wells, Jack N ^a   Francis, Sharron H ^a   Sekhar, Konjeti R ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

8(IAB) IBMX; 8(IAB)-IBMX; CGMP BINDING, CGMP SPECIFIC 3',5' CYCLIC NUCLEOTIDE PHOSPHODIESTERASE; CGMP-BINDING, CGMP-SPECIFIC 3',5'-CYCLIC NUCLEOTIDE PHOSPHODIESTERASE; CYCLIC AMP; CYCLIC GMP; CYCLIC GMP PHOSPHODIESTERASE; DRUG DERIVATIVE; ISOBUTYLMETHYLXANTHINE; RADIOACTIVE IODINE;

ANIMAL; ARTICLE; BINDING COMPETITION; BINDING SITE; CATALYSIS; CATTLE; CHEMISTRY; DRUG EFFECT; METABOLISM; PHOTOAFFINITY LABELING; SYNTHESIS;

1-METHYL-3-ISOBUTYLXANTHINE; 3',5'-CYCLIC-GMP PHOSPHODIESTERASE; ALLOSTERIC SITE; ANIMALS; BINDING SITES; BINDING, COMPETITIVE; CATALYSIS; CATTLE; CYCLIC AMP; CYCLIC GMP; IODINE RADIOISOTOPES; PHOTOAFFINITY LABELS;

EID: 0031633373     PISSN: 10859195     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02737833     Document Type: Article

References (20)

1. Waldman, S. A. and Murad, F. (1987) Cyclic GMP synthesis and function. Pharmacol. Rev. 39, 163-196.
2. Garbers, D. L. (1989) Guanylate cyclase, a cell surface receptor. J. Biol Chem 265, 9103-9106.
3. Corbin, J. D., Thomas, M. K., Wolfe, L., Shabb, J. B., Woodford, T. A. and Francis, S. H. (1990) New insights into cGMP action. Adv. Second Messenger Phosphoprotein Res., 24, 411-418.
4. Beavo, J. A., Conti, M., and Heaslip, R. J. (1994) Multiple cyclic nucleotide phosphodiesterases. Mol. Pharmacol. 46(3), 399-405.
5. Conti, M., Nmoz, G., Sette, C., and Vincini, E. (1995) Recent progress in understanding the hormonal regulation of phosphodiesterases. Endoc. Res. 16(3), 370-389.
6. Manganiello, V. C., Taira, M., Degerman, E., and Belfrage, P. (1995) Type II cGMP-inhibited cyclic nucleotide phosphodiesterases (PDE3 gene family). Cell. Signalling 7(5), 445-455.
7. Houslay, M. (1995) Compartmentalization of cyclic AMP phosphodiesterases, signalling "crosstalk," desensitization and the phosphorylation of Gi-2 add cell specific personalization to the control of the levels of the second messenger cAMP. Adv. Enz. Reg. 35, 303-338.
8. Bolger, G. B. (1994) Molecular biology of the cyclic AMP-specific cyclic nucleotide phosphodiesterases: a diverse family of regulatory enzymes. Cell. Signalling 6(8), 851-859.
9. Thompson, W. J., Lavis, V. W., Whalin, M. E., and Strada, S. J. (1992) Regulatory mechanisms of particular cyclic nucleotide phosphodiesterases. Adv. Second Mess. Phosphoprot. Res. 25, 165-184.
10. Thomas, M. K., Francis, S. H., and Corbin, J. D. (1990) Substrate- and kinase-directed regulation of a cGMP-binding phosphodiesterase by cGMP. J. Biol. Chem. 265, 14,971-14,978.
11. Martins, T. J., Mumby, M. C., and Beavo, J. A. (1982) Purification and characterization of a cyclic GMP-stimulated cyclic nucleotide phosphodiesterase from bovine tissues. J. Biol. Chem. 257, 1973-1979.
12. Tamazaki, A., Uchida, S., Stein, P. J., Wheeler, G. L., and Bitensky, M. W. (1984) Enzyme regulation and GTP-binding protein: An algorithm of control that includes physical displacement of an inhibitory protein, in Adv. Cyclic Nucleotide and Protein Phosphorylation Res., Raven, New York, pp. 381-392.
13. Stroop, S. D., Charbonneau, H., and Beavo, J. A. (1989) Direct photolabeling of the cGMP-stimulated cyclic nucleotide phosphodiesterase. J. Biol. Chem. 254, 13,718-13,725.
14. Grant, P. H., DeCamp, D. L., Bailey, J.I., Colman, R. F., and Colman, R. W. (1992) Low-Km cyclic AMP phosphodiesterase from human platelets. Stimulation of activity by phosphorylation of the enzyme and affinity labeling of the active site. Adv. Second Messenger Phosphoprotein Res. 25, 73-85.
15. Omburo, G. A., Torphy, T. J., Scott, G., Jacobitz, S., Colman, R. F., and Colman, R. W. (1997) Inactivation of recombinant monocyte cAMP-specific phosphodiesterase by cAMP analog, 8-[(4-bromo-2,3-dioxobutyl)thio]adenosine 3′,5′-cyclic monophosphate. Blood 89(3), 1019-1026.
16. Sekhar, K. R., Grondin, P., Francis, S. H., and Corbin, J. D. (1996) Design and synthesis of xanthines and cyclic GMP analogues as potent inhibitors of PDE5, in Handbook of Immunopharmacology (Schudt, C., ed.), Academic, San Diego, CA, pp. 135-146.
17. 125I-azido-BW-A844U, a photoaffinity label. Mol. Pharmacol. 33, 585-591.
18. Turko, I. V., Haik, T. L., McAllister-Lucas, L. M., Burns, F., Francis, S. H., and Corbin, J. D. (1996) Identification of key amino acids in a conserved cGMP-binding site of cGMP-binding phosphodiesterases. J. Biol. Chem. 271, 22,240-22,244.
19. Wells, J. N. and Miller, J. R. (1988) Methylxanthine inhibitors of phosphodiesterases. Methods Enzymol, 159, 489-496.
20. Katsushima, T., Nieves, L., and Wells, J. N. (1990) Structure-activity relationships of 8-cycloalkyl-1,3-dipropylxanthines as antagonists of adenosine receptors. J. Med. Chem. 33, 1906-1910.